The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide feedback on the “Medicare $2 Drug List Model” issued by CMS. AMCP supports the initiative's goal of lowering prescription drug costs and increasing access to generics, which can enhance patient health outcomes and reduce financial strain. The organization highlights the benefits of generics as safe, cost-effective alternatives and recommends STARS incentives to encourage participation. AMCP also expresses willingness to assist with outreach efforts but advises CMS to remain cautious about unintended consequences, such as limiting plan options or creating operational challenges with out-of-network pharmacies. Flexibility in drug selection and ensuring the model applies only to in-network providers are key considerations for successful implementation.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
